A Randomized, Double-Blind, Parallel Group, Multicenter, Stratified St
Research payments
$1,319,320
Through program year 2020, $1,319,320 in research payments was reported against A Randomized, Double-Blind, Parallel Group, Multicenter, Stratified St, across 188 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $193,462 | 51 |
| 2019 | Research | $1,125,859 | 137 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Moss Madison, WI Named on 19 payments
- Mark Liu Baltimore, MD Named on 13 payments
- Barry Heller Long Beach, CA Named on 10 payments
- Sally Wenzel Pittsburgh, PA Named on 9 payments
- Alberto Manzor Pembroke Pines, FL Named on 8 payments
- David Fuentes Boerne, TX Named on 8 payments
- David Bernstein Cincinnati, OH Named on 8 payments
- Javier Reyna Miami Beach, FL Named on 7 payments
- Stephen Tilley Chapel Hill, NC Named on 6 payments
- Sever Surdulescu Mooresville, NC Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.